Namrata Shirodkar proud of sister Shilpa for receiving COVID-19 vaccine, gets


The last few weeks in the COVID-19 pandemic has been dominated about discussions on the rolling out of vaccines. While India’s approval of two vaccines became a talking point last week, numerous countries have already kicked off the vaccination process.  As Indians awaited the vaccine, Shilpa Shirodkar became the first celebrity from the Indian film industry to get vaccinated in Dubai recently.

READ: Shilpa Shirodkar Becomes First Bollywood Actor To Get COVID-19 Vaccine In Dubai

Shilpa Shirodkar gets vaccinated for COVID-19

Shilpa Shirodkar, who has featured in numerous films and TV shows right from ‘90s till Savitri Devi College & Hospital few years ago, recently announced on Instagram that she had got vaccinated in Dubai. The Kishen Kanhaiya star called herself ‘safe’ as she shared a picture showcasing her arm on which she was vaccinated. She conveyed her gratitude to the UAE government. 

Her sister Namrata Shirokar too was excited and called Shilpa ‘good girl’. The former Miss World and actress, who is also the wife of Telugu superstar Mahesh Babu, got a sweet response from Shilpa. The latter wrote in Marathi, ‘tujicH bahin’, which meant she was like her sister.  

READ: Mahesh Babu & Namrata Shirodhkar Aid People In Need Of Heart Surgeries This Christmas

India’s vaccination process 

While countries like USA, UK, Israel and more have already begun vaccinating their citizens, India is set to start the process from January 13. The dry run is currently underway in various states. 

Last week, it was announced that Bharat Biotech’s Covaxin and Covishield, to be manufactured  by Serum Institute of India with Oxford University-AstraZeneca have been approved by the Drug Controller General of India (DGCI).

The DGCI issued the following statement on the approval of the vaccines:

The Subject Expert Committee of Central Drugs Standard Control Organisation (CDSCO) met on 1st and 2nd January, 2021 and made recommendations in respect of proposal for Restricted Emergency Approval of COVID-19 virus vaccine of M/s Serum Institute of India and M/s Bharat Biotech as well as Phase III clinical trial of M/s Cadila Healthcare Ltd.
The Subject Expert Committee consists of domain knowledge experts from the fields of pulmonology, immunology, microbiology, pharmacology, paediatrics, internal medicine, etc.

M/s Serum Institute of India, Pune has presented a Recombinant Chimpanzee Adenovirus vector vaccine (Covishield) encoding the SARS-CoV-2 Spike (S) glycoprotein with technology transfer from AstraZeneca/Oxford University. The firm submitted safety, immunogenicity and efficacy data generated on 23,745 participants aged ≥ 18 years or older from overseas clinical studies. The overall vaccine efficacy was found to be 70.42%. Further, M/s Serum was granted permission to conduct Phase-II/III clinical trial on 1600 participants within the country. The firm also submitted the interim safety and…

Read More: Namrata Shirodkar proud of sister Shilpa for receiving COVID-19 vaccine, gets

Leave a reply